However, chronic acid reflux, occurring more than twice a week, may indicate GERD
For patients who are unwilling or fearful of injections, oral form is clearly a more friendly option
Several have active or recent FDA actions, so vet accordingly
(December 2025)
For MS patients taking disease-modifying therapies (DMTs), specific considerations include: Oral DMTs (fingolimod, siponimod, ozanimod, ponesimod, teriflunomide, dimethyl fumarate, diroximel fumarate): Semaglutide may delay absorption
This happens frequently in high-volume telehealth practices where standardized instructions may not account for pharmacy variations